- Residency and Fellowship Programs
- Advanced Airway Management Fellowship
- Advanced Colon and Rectal Surgical Oncology Fellowship
- Advanced Radiation Oncology Fellowship
- Advanced Therapeutic Endoscopy Fellowship
- Blood Banking/Transfusion Medicine Fellowship
- Body Imaging Fellowship
- Breast Imaging Fellowship
- Breast Surgical Oncology Fellowship
- Cancer Anesthesia Residency/Fellowship
- Cancer Rehabilitation Fellowship
- Chemical Pathology Fellowship
- Complex General Surgical Oncology Fellowship
- Cytopathology Fellowship
- Dermatopathology Fellowship
- Diagnostic Radiology Fellowship
- General Internal Medicine Fellowship
- General Internal Medicine Onco-Hospitalist Fellowship
- Gynecologic Oncology Fellowship
- Head and Neck Surgical Oncology and Reconstruction Fellowship
- Hematology/Oncology Fellowship Program
- Hematopathology Fellowship
- Hospice and Palliative Medicine Fellowships
- Internal Medicine Residency Program
- Interventional Pulmonology Fellowship
- Interventional Radiology Independent Residency
- Interventional Radiology Integrated Residency
- Investigational Cancer Therapeutics Fellowship
- Leukemia Fellowship
- Lymphoma/Myeloma Fellowship
- Melanoma Oncology Fellowship
- Micrographic Surgery & Dermatologic Oncology Fellowship
- Microvascular Reconstructive Surgery
- Molecular Genetic Pathology Fellowship
- Musculoskeletal Oncology Fellowship
- Musculoskeletal Radiology Fellowship
- Neuro-Oncology Fellowship
- Neurosurgical Oncology Fellowship
- Oncologic Emergency Medicine Fellowship
- Oncologic Endocrinology Fellowship
- Onco-nephrology Fellowship
- Oncological Neuroradiology
- Ophthalmic Plastic and Reconstructive Surgery Fellowship (ASOPRS /ACGME)
- Oral Oncology & Maxillofacial Prosthetics
- Pain Medicine Fellowship
- Pediatric Hematology & Oncology Fellowship
- Pediatric Hospice and Palliative Medicine Fellowship
- Radiation Oncology Residency
- Regional Anesthesia and Acute Pain Medicine Fellowship
- Selective Breast Pathology Fellowship
- Selective Cancer Biomarker Pathology Fellowship
- Selective Gastrointestinal & Liver Pathology Fellowship
- Selective Genitourinary Pathology Fellowship
- Selective Gynecologic Pathology Fellowship
- Selective Head & Neck Pathology Fellowship
- Selective Soft Tissue Pathology Fellowship
- Selective Surgical Pathology Fellowship
- Selective Thoracic Pathology Fellowship
- Stem Cell Transplantation and Cellular Therapy
- Surgical Endocrinology Fellowship
- Thoracic Head & Neck Medical Oncology Fellowship
- Thoracic Radiology Fellowship
- Thoracic Surgery Fellowship
- Urinary Tract and Pelvic Reconstruction Fellowship
- Urologic Oncology Fellowship
Radiation Oncology Residency
The MD Anderson residency program in radiation oncology is an advanced, four-year program certified by the Accreditation Council for Graduate Medical Education. The program provides comprehensive clinical training to physicians preparing to practice full-time radiation oncology and introduces them to clinical and/or laboratory-based research. Our goal is to develop the careers of future leaders in academic radiation oncology.
At the completion of the program, our residents are well-versed in the overall management of radiotherapy cases and are proficient with advanced radiotherapy techniques and brachytherapy procedures. Residents participate at all levels of care, including consultation, treatment planning and evaluation, weekly assessment, and follow-up, and are expected to assume increasing responsibilities commensurate with their level of experience.
Objectives
- To provide a robust educational experience for clinical training in radiation oncology, with the comprehensive understanding of oncologic principles, treatment techniques, dosimetry, physics, and radiobiology
- To provide a clinical learning environment that promotes expertise in oncology, with exposure to treatment for the full spectrum of disease sites, the pathology of each disease site, radiographic findings and the surgical and medical options
- To foster a multidisciplinary approach to cancer care through participation in disease site-oriented conferences that combine highly specialized medical oncologists, surgical oncologists, pathologists and radiologists
- To introduce and promote clinical research through retrospective and prospective evaluations of patient outcomes
Example Rotation Schedule
|
Block 1 |
Block 2 |
Block 3 |
Block 4 |
Block 5 |
Block 6 |
|---|---|---|---|---|---|---|
PGY-2 |
Breast (1) |
Genitourinary (1) |
Gynecology (1) |
Head & Neck (1) |
Thoracic (1) |
CNS/Peds (1) |
PGY-3 |
Breast (2) |
Melanoma/Sarcoma |
Gastrointestinal |
Head & Neck (2) |
Lymphoma |
CNS/Peds (2) |
PGY-4 |
Research |
Research |
Research |
Research |
Research |
Research |
PGY-5 |
Selective* |
Genitourinary (2) |
Gynecology (2) |
Selective* |
Thoracic (2) |
Elective |
*Selective rotation: Head & Neck or Gastrointestinal or Remote (Community) Cancer Center (RCC)
Meet Our Residents and Fellows
How to Apply
Applications are accepted exclusively through the Electronic Residency Application Services (ERAS) of the Association of American Medical Colleges. All regular residency program positions are filled through participation in the National Resident Matching Program.
Applications must be completed and submitted by October 15. After a favorable review, the committee requests a personal interview with the prospective trainee. Interviews are given by invitation only and are scheduled in one of four interview sessions. The Training Committee interviews up to eight candidates each week on selected Fridays in December and January.
Our program was one of the signatories of the red journal commentary, ‘Taking “the Game” Out of the Match: A Simple Proposal.’
- We are committed to the letter and the spirit of NRMP rules.
- We will not solicit any information from applicants on how high we are on their rank list. We strongly discourage applicants from volunteering such information. We will not answer emails, letters or thank-you notes. Please understand that thank-you notes are not necessary.
- We will not directly or indirectly divulge to applicants their position on the rank list. Our program director, chair and faculty will refrain from post-interview communication.
- After the interview day, applicants desiring more information about our program will be directed to the program coordinator.
- Applicants may report potential violations of match policies or principles to this online suggestion box: https://www.suggestionox.com/r/ncmMin
References
Wu, A. J., Vapiwala, N., Chmura, S. J., Das, P., Decker, R. H., Terezakis, S. A., & Zietman, A. L. (2015). Taking "the Game" Out of The Match: A Simple Proposal. International journal of radiation oncology, biology, physics, 93(5), 945–948. https://doi.org/10.1016/j.ijrobp.2015.09.039
Contact Information
Chelsea C. Pinnix, M.D., Ph.D.
Residency Program Director
Denise De La Cruz, M.Ed.
Program Administrator, Education & Training
Division of Radiation Oncology - Unit 1422
The University of Texas MD Anderson Cancer Center
1400 Pressler St., FCT6.5000
Houston, TX 77030
Phone: 713-792-2534
Fax: 713-563-8645
Email: ddlcruz@mdanderson.org
MD Anderson Cancer Center is committed to encouraging good health and staying true to our mission to end cancer. If you are applying for a GME fellowship or residency program starting on or after July 1, 2016, please be advised that MD Anderson will have instituted a tobacco-free hiring process as part of its efforts to achieve these goals. If you are offered an appointment, you will be subject to a Pre-Employment Drug Screen for tobacco compounds in compliance with applicable state laws. If you do not pass the urine drug screening which includes testing for tobacco compounds, you CANNOT be appointed at MD Anderson. Should you fail to meet this contingency, MD Anderson will withdraw your offer of appointment for the academic year. You may reapply for the following academic year, but there are no guarantees that you will be offered a position as many of our programs are already filled for several years out.